Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDC42 pseudogene 2 (abbreviated as CDC42P2) is classified as a pseudogene in the human genome[1][2][3]. As a pseudogene, it shares sequence similarity with the functional CDC42 gene but does not code for a functional protein product. Pseudogenes generally lack biological function and are not targets for drugs, biomarkers, or therapeutic modulation. No evidence supports any disease association, biological role, or interaction with drugs for CDC42P2. CDC42P2 should not be confused with CDC42, which encodes the small GTPase Cell division control protein 42 homolog and has well-established biological and disease relevance[4][5]. CDC42P2 itself has none of these properties, as it is a non-functional gene copy. There are no reported aliases beyond CDC42P2 in standard databases[1][2][3]. As a pseudogene, CDC42P2 lacks classification within typical druggable target families such as enzymes, receptors, or transporters[1][2][3]. Overall, CDC42P2 is not a therapeutic target and has no current known functional or clinical significance. If you are seeking information about a therapeutic target, it is likely you are interested in the canonical CDC42 gene (Cell division control protein 42 homolog), not this pseudogene[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDC42 pseudogene 2 (CDC42P2).